Ivory raises fresh capital to strengthen deep tech offerings

Ivory, a brain health platform focused on early cognitive screening, has raised $1M in fresh funding, onboarding new investors to deepen its product, clinical, and IP capabilities.

The round saw participation from Draper Associates, a global venture capital firm with a strong focus on biotech and healthtech, along with SAGE Venture Fund, an AIF fund launched by Ministry of Social Justice and Empowerment (MoSJE) (selection partners for Startups) and managed by IFCI Venture, a subsidiary of IFCI Limited and Small Industries Development Bank of India (SIDBI). The investment reflects growing institutional interest in preventive health platforms that are building for scale and real-world impact.

With this capital, the company plans to further strengthen its technology stack, expand clinical capabilities, and enhance its product offerings particularly in building scalable, evidence-based solutions that integrate seamlessly across both consumer and clinical workflows.

Rahul Krishnan, Co-founder & CPO, Ivory, said “Preventive healthcare in India is at an inflection point, but cognitive health has largely remained outside this shift. Our focus at Ivory is to make brain health measurable and actionable, much like other key health biomarkers. This round allows us to deepen our clinical and product capabilities, while continuing to build a scalable, digital-first layer for cognitive screening across both consumers and healthcare systems.”

Anish Babu, Managing Director, IFCI Venture, said “We are seeing strong momentum in startups building for preventive healthcare and large-scale health impact. Ivory is addressing a significant unmet need in cognitive health through a clinically grounded and technology-led approach. We are pleased to support their journey as they work towards making early cognitive screening more accessible and mainstream in India.”

Most recently, Ivory collaborated with Metropolis Healthcare to launch the TruHealth Mind & Body package.